Oxidative Stress Induced by the Chemotherapeutic Agent Arsenic Trioxide

Overview

Journal 3 Biotech

Publisher Springer

Specialty Biotechnology

Date 2017 Mar 22

PMID 28324479

Citations 5

Authors

Mathews V Varghese

Alex Manju

M Abhilash

M V Sauganth Paul

S Abhilash

R Harikumaran Nair

Affiliations

Soon will be listed here.

Abstract

Arsenic compounds have been used for medicinal purposes throughout history. Arsenic trioxide (AsO) achieved dramatic remissions in patients with acute promyelocytic leukaemia. Unfortunately, the clinical usefulness of AsO has been limited by its toxicity. The present study was designed to investigate the toxic effects of AsO at its clinical concentrations. Experimental rats were administered with AsO 2, 4 and 8 mg/kg body weight for a period of 45 days and the serum glucose, creatine kinase, lactate dehydrogenase, lipid peroxidation and antioxidant status were measured. AsO-treated rats showed elevated serum glucose, creatine kinase and lactate dehydrogenase concentrations. Lipid peroxidation product malondialdehyde was found to be produced more in arsenic-treated rats. Reduced glutathione and glutathione-dependant antioxidant enzymes, glutathione-S-transferase and glutathione peroxidase, and the antiperoxidative enzymes, superoxide dismutase and catalase, concentrations were reduced with the AsO treatment. All these toxic effects were found increased with the increase in concentration of AsO. The results of the study indicate that AsO produced dose-dependant toxic side effects at its clinical concentrations.

Citing Articles

Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses.

Mannan A, Germon Z, Chamberlain J, Sillar J, Nixon B, Dun M Antioxidants (Basel). 2021; 10(10).

PMID: 34679751 PMC: 8533157. DOI: 10.3390/antiox10101616.

Magnesium Isoglycyrrhizinate Alleviates Arsenic Trioxide-Induced Cardiotoxicity: Contribution of Nrf2 and TLR4/NF-κB Signaling Pathway.

Zheng B, Yang Y, Li J, Li J, Zuo S, Chu X Drug Des Devel Ther. 2021; 15:543-556.

PMID: 33603344 PMC: 7886103. DOI: 10.2147/DDDT.S296405.

Protective Effects of Crocetin on Arsenic Trioxide-Induced Hepatic Injury: Involvement of Suppression in Oxidative Stress and Inflammation Through Activation of Nrf2 Signaling Pathway in Rats.

Liu Y, Liang Y, Zheng B, Chu L, Ma D, Wang H Drug Des Devel Ther. 2020; 14:1921-1931.

PMID: 32546959 PMC: 7245440. DOI: 10.2147/DDDT.S247947.

Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

Kania G, Rudnik M, Distler O Nat Rev Rheumatol. 2019; 15(5):288-302.

PMID: 30953037 DOI: 10.1038/s41584-019-0212-z.

Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatment.

Glorieux C, Buc Calderon P Cancer Cell Int. 2018; 18:24.

PMID: 29467594 PMC: 5819285. DOI: 10.1186/s12935-018-0524-0.

References

Beutler E, Duron O, Kelly B . Improved method for the determination of blood glutathione. J Lab Clin Med. 1963; 61:882-8. View

Paoletti F, Aldinucci D, Mocali A, Caparrini A . A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem. 1986; 154(2):536-41. DOI: 10.1016/0003-2697(86)90026-6. View

Tseng C, Chong C, Tseng C, Hsueh Y, Chiou H, Tseng C . Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett. 2002; 137(1-2):15-21. DOI: 10.1016/s0378-4274(02)00377-6. View

Hughes M . Arsenic toxicity and potential mechanisms of action. Toxicol Lett. 2002; 133(1):1-16. DOI: 10.1016/s0378-4274(02)00084-x. View

Soignet S, Frankel S, Douer D, Tallman M, Kantarjian H, Calleja E . United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol. 2001; 19(18):3852-60. DOI: 10.1200/JCO.2001.19.18.3852. View

Ratnaike R . Acute and chronic arsenic toxicity. Postgrad Med J. 2003; 79(933):391-6. PMC: 1742758. DOI: 10.1136/pmj.79.933.391. View

Paglia D, Valentine W . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70(1):158-69. View

Mathews V, Paul M, Abhilash M, Manju A, Abhilash S, Nair R . Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide. Eur Rev Med Pharmacol Sci. 2013; 17 Suppl 1:34-8. View

Wang Z, Chen Z . Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008; 111(5):2505-15. DOI: 10.1182/blood-2007-07-102798. View

10.

AEBI H . Catalase in vitro. Methods Enzymol. 1984; 105:121-6. DOI: 10.1016/s0076-6879(84)05016-3. View

11.

Raghu K, Yadav G, Singh R, Prathapan A, Sharma S, Bhadauria S . Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug. J Environ Pathol Toxicol Oncol. 2009; 28(3):241-52. DOI: 10.1615/jenvironpatholtoxicoloncol.v28.i3.60. View

12.

Maiti , Chatterjee . Differential response of cellular antioxidant mechanism of liver and kidney to arsenic exposure and its relation to dietary protein deficiency. Environ Toxicol Pharmacol. 2000; 8(4):227-235. DOI: 10.1016/s1382-6689(00)00046-6. View

13.

Liu S, Athar M, Lippai I, Waldren C, Hei T . Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc Natl Acad Sci U S A. 2001; 98(4):1643-8. PMC: 29310. DOI: 10.1073/pnas.98.4.1643. View

14.

Mathews V, Paul M, Abhilash M, Manju A, Abhilash S, Nair R . Mitigation of hepatotoxic effects of arsenic trioxide through omega-3 fatty acid in rats. Toxicol Ind Health. 2012; 30(9):806-13. DOI: 10.1177/0748233712463778. View

15.

Basu A, Mahata J, Gupta S, Giri A . Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res. 2001; 488(2):171-94. DOI: 10.1016/s1383-5742(01)00056-4. View

16.

Flora S . Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med. 2011; 51(2):257-81. DOI: 10.1016/j.freeradbiomed.2011.04.008. View

17.

Datta K, Sinha S, Chattopadhyay P . Reactive oxygen species in health and disease. Natl Med J India. 2001; 13(6):304-10. View

18.

Tchounwou P, Wilson B, Ishaque A . Important considerations in the development of public health advisories for arsenic and arsenic-containing compounds in drinking water. Rev Environ Health. 2000; 14(4):211-29. DOI: 10.1515/reveh.1999.14.4.211. View

19.

Beutler E, Gelbart T, Pegelow C . Erythrocyte glutathione synthetase deficiency leads not only to glutathione but also to glutathione-S-transferase deficiency. J Clin Invest. 1986; 77(1):38-41. PMC: 423305. DOI: 10.1172/JCI112298. View

20.

Thompson J, White C, Cox D, Chan J, Kavanagh T, Fausto N . Distinct Nrf1/2-independent mechanisms mediate As 3+-induced glutamate-cysteine ligase subunit gene expression in murine hepatocytes. Free Radic Biol Med. 2009; 46(12):1614-25. PMC: 2748780. DOI: 10.1016/j.freeradbiomed.2009.03.016. View